Extended Stability for Parenteral Drugs

The only guide to extended beyond-use dating of parenteral drugs.

Available in June 2023 through MedicinesComplete, Extended Stability for Parenteral Drugs supports safe extended dating of parenteral drugs beyond the usual 24-hour limit – minimising waste and lowering medicines costs. The indispensable, go-to reference for anyone preparing, administering, or compounding medicines for use in patients.

Sales and Upgrades Content Updates

Quickly access real-world extended stability information for the most commonly used IV solutions, medications, and administration devices

Safely extend beyond-use dating of parenteral medications

Reduce medicines costs

Minimise medicines waste from partial dosing or when temperature excursions occur, particularly for expensive drugs and drugs in short supply

Enable optimal patient administration schedules at alternate infusion sites

Allows medicines to be prepared in bulk or ahead of time

Extended Stability for Parenteral Drugs provides:

196 monographs, each including extended drug stability data specific to: container, drug manufacturer, concentration, and diluent
An extensive list of medications with temperature excursion data for intact vials
Provides coverage of all aspects of determining stability, including the changing elastomeric landscape and the ongoing variability in stability data
Monographs inclusive of all clinical settings where parenteral drugs are stored or compounded, in addition to alternative site infusions
Stability timeframes including standardised temperatures for room, refrigerated, frozen, post thaw, and body temperatures
Newly published stability information for parenteral nutrition, oncology, specialty, and COVID medications
Stability data presented in user-friendly, easy to digest tables
Monographs linked to relevant information in ASHP Injectable Drug Information

196

drug monographs

new stability monographs

808

references

2 editors

with 13 contributing writers